What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Pathology
The scientist’s investigation covers issues in Pathology, Internal medicine, Gastroenterology, Cirrhosis and Hepatitis. Kamal G. Ishak works mostly in the field of Pathology, limiting it down to topics relating to Viral hepatitis and, in certain cases, Metabolite, as a part of the same area of interest. His Internal medicine study frequently links to adjacent areas such as Endocrinology.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Eosinophilia, Carcinoma and Hyperplasia. His Cirrhosis research is multidisciplinary, incorporating perspectives in Steatosis, Epidemiology, Liver function tests, Liver disease and Hepatocellular carcinoma. His Hepatitis study incorporates themes from Biopsy and Hepatitis C.
His most cited work include:
- Histological grading and staging of chronic hepatitis. (3856 citations)
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis (3097 citations)
- Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. (528 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Pathology, Internal medicine, Gastroenterology, Hepatitis and Cirrhosis. His Pathology study integrates concerns from other disciplines, such as Hepatocellular carcinoma and Cholestasis. The Internal medicine study combines topics in areas such as Endocrinology and Surgery.
His research integrates issues of Eosinophilia, Liver injury, Hepatitis C and Epidemiology in his study of Gastroenterology. His work carried out in the field of Hepatitis brings together such families of science as Viral hepatitis and Chronic hepatitis. His studies in Cirrhosis integrate themes in fields like Liver disease and Steatosis.
He most often published in these fields:
- Pathology (61.69%)
- Internal medicine (33.77%)
- Gastroenterology (25.32%)
What were the highlights of his more recent work (between 1998-2018)?
- Pathology (61.69%)
- Immunohistochemistry (7.79%)
- Internal medicine (33.77%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Pathology, Immunohistochemistry, Internal medicine, Anatomy and Epithelioid cell. The study incorporates disciplines such as Cholestasis and Angiomyolipoma in addition to Pathology. In his study, which falls under the umbrella issue of Immunohistochemistry, Adenocarcinoma is strongly linked to Carcinoma.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Lesion. His Gastroenterology study focuses on Cirrhosis in particular. His Histopathology research incorporates elements of Nodular regenerative hyperplasia, Surgery and General surgery.
Between 1998 and 2018, his most popular works were:
- Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. (402 citations)
- Valproate-induced hepatic injury: analyses of 23 fatal cases. (322 citations)
- Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study (287 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Pathology
His main research concerns Pathology, Anatomy, Epithelioid cell, Immunohistochemistry and Angiomyolipoma. His study connects Steatosis and Pathology. Kamal G. Ishak combines subjects such as Fibrous capsule of Glisson, Intrahepatic bile ducts and Perivascular Epithelioid Cell with his study of Anatomy.
His biological study spans a wide range of topics, including CD31, Univariate analysis, Nuclear atypia, Epithelioid hemangioendothelioma and Transplantation. His Immunohistochemistry study combines topics in areas such as Mallory body and Carcinoma, Clear cell carcinoma. Kamal G. Ishak interconnects Cell, Staining and Growth factor receptor in the investigation of issues within Angiomyolipoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
